Verici Dx (LON:VRCI) Trading Down 14.7% – What’s Next?

Verici Dx plc (LON:VRCI)’s share price traded down 14.7% during mid-day trading on Thursday . The stock traded as low as GBX 1.07 ($0.01) and last traded at GBX 1.07 ($0.01). 506,862 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,088,881 shares. The stock had previously closed at GBX 1.25 ($0.02).

Verici Dx Price Performance

The stock’s 50-day moving average is GBX 1.86 and its 200-day moving average is GBX 2.85. The firm has a market cap of £3.24 million, a P/E ratio of -0.62 and a beta of 1.59. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.